Current concepts in malignant pleural mesothelioma. - Wikidata - wikimedia - TriplyDB

Current concepts in malignant pleural mesothelioma.

Current concepts in malignant pleural mesothelioma.

http://www.wikidata.org/entity/Q37086026

about

Ranpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft Growth miR-1 induces growth arrest and apoptosis in malignant mesothelioma hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.Diagnostic and prognostic biomarkers for malignant mesothelioma: an update.Novel therapies in phase II and III trials for malignant pleural mesothelioma.Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.Spontaneous mesotheliomas in F344/N rats are characterized by dysregulation of cellular growth and immune function pathways.Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.Mesothelioma epidemiology, carcinogenesis, and pathogenesis.Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma.Role of microRNAs in malignant mesothelioma.Onconase mediated NFKβ downregulation in malignant pleural mesothelioma.Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.

P2860

Q24612464-EEE91F2D-6490-42D7-B434-9492BD8D6EDB Q28397782-77635F38-B323-4A0C-AF77-90D72145DCD9 Q33699231-FA2B69A1-9F3C-48F5-99BA-3DD5FC5526B9 Q33890558-C770E286-CDB7-4C3B-99A9-52C4962D75AD Q35129535-38A738AF-52BF-4B1C-8229-E467442187BA Q35699080-9E0D4064-808F-4694-B641-8938EE14BD65 Q36394044-CFCF1F51-3024-44EB-B8E3-A1502FCA5FCD Q37141355-2BE4CD0D-E67A-4782-844C-3E2C900E7F35 Q37179384-5B084165-85BC-4373-A39F-24B8111D7433 Q37246002-11FB7DC8-E5CE-4956-8922-99D9FF0EFC82 Q37562633-7CD4EB06-0733-4558-BEB1-529143B5E0B6 Q38190418-35A12CB8-6888-4036-A152-3E4EBE56EE52 Q39593000-0EBCA218-6A09-42E8-B02A-671FF954C97F Q41856729-9EDE46A4-A60D-4BBD-B82E-9DC72C85CA5B Q43466291-92D06EDE-F95D-405B-B0F5-9B394AA58A58 Q49804857-9FAA2600-0F39-46FB-916F-E0EC115F239C

P2860

Current concepts in malignant pleural mesothelioma.

http://www.wikidata.org/entity/Q37086026

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current concepts in malignant pleural mesothelioma.

@en

Current concepts in malignant pleural mesothelioma.

@nl

type

label

Current concepts in malignant pleural mesothelioma.

@en

Current concepts in malignant pleural mesothelioma.

@nl

prefLabel

Current concepts in malignant pleural mesothelioma.

@en

Current concepts in malignant pleural mesothelioma.

@nl

P1433

Q37086026-7DCC2E1E-57A0-4C45-B221-E41542B0B729

P1476

Q37086026-F2F08EEC-52C7-4BF7-9F22-03BA59FA5774

P2093

Q37086026-DCF07A9F-E5E1-4728-9ACE-572E787A9C5E

P2860

Q37086026-02D95B0F-03C2-47B1-807B-BA506AE1D21C

Q37086026-070BF4B2-A9CF-4081-830B-552A3121B263

Q37086026-0C09CAC9-B4B4-4CC1-9F26-9327C3E94DD2

Q37086026-110D9F2C-F97E-4165-B560-1388299C3DD7

Q37086026-19A61A50-0967-4409-9989-7466E8F2D39A

Q37086026-19F9260A-745E-42D8-A8CE-A09EB9672C42

Q37086026-1C8B4BBA-E47A-45B0-8691-744D9B132B1C

Q37086026-206F265D-E216-4EDC-90C5-F815E64A5A72

Q37086026-28E1CB45-859C-43C7-BE18-7A6D2EA14B5B

Q37086026-38FA6CD8-7A63-4535-A7E5-E36D96433DE3

P304

Q37086026-36574C35-4411-4837-B359-35A17ECDCBBD

P31

Q37086026-32E7A0E3-727C-4366-81AB-C16A2C13E979

P356

Q37086026-B398080B-7B8F-4125-BF71-F822112DFD1A

P433

Q37086026-0618A4E1-7BFD-4AFF-8F39-8D29E71FF5B5

P478

Q37086026-8E746A07-B515-49FA-AF0D-42499271BD68

P50

Q37086026-63FD3A7A-EADD-48F0-A442-47F09F85990C

P577

Q37086026-7E1A2E36-8C78-459D-B2CF-8EEA6EDDB7F4

P698

Q37086026-E5841D05-5CD7-4E00-8135-C9F4DF818409

P356

14737140.8.2.293

P1433

Expert Review of Anticancer Therapy

P1476

Current concepts in malignant pleural mesothelioma

@en

P2093

Andrew J Kaufman

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 6 induces the expression of vascular endothelial growth factor

The European mesothelioma epidemic

Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters

Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species.

MESOMARK: a potential test for malignant pleural mesothelioma

mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats

TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis

Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase.

Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.

P304

293-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.8.2.293

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18279069

http://www.w3.org/2001/XMLSchema#string